EMA (EU)
EVENT
Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines
Published: 11/20/2026Detected: 11/14/2026
Summary preview
Addresses operational improvements to the EMA centralized procedure for human medicines, with a particular focus on implementing new EU pharmaceutical legislation across delivery streams.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
rare_diseases
pediatrics
oncology
#EMA centralized procedure
#assessment report revamp
#QRD template
#pre-submission interactions pilot
#ASMF
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026
- Clinical Trials Information System (CTIS) bitesize talk: CTIS training environment and role management11/18/2026